FDA approves Pfizer's eczema ointment

FDA approves Pfizer's eczema ointment


Dec 14 The U.S. Food and Drug Administration said on Wednesday it had approved Pfizer Inc's Eucrisa ointment to treat mild-to-moderate eczema, or atopic dermatitis, in patients two years and older. Atopic dermatitis is the most common of the many types of eczema, typically beginning in childhood and possibly lasting through adulthood.



from Biotech News